Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Who's Afraid Of A Tweet And A Pin? Strategies To Start Engaging Online

Executive Summary

Lubna Ahmed explores how pharma can benefit from using social media, where the industry is at now and the different ways it could make the most out of the tools that have become centerpieces of our world's communication.

You may also be interested in...



Social Media/Mobile Health Data: What's It Good For?

Whether its tweets on Twitter, posts on Facebook or vital signs being recorded by wearable fitness trackers and cell phone apps, the data from social media and mobile health devices have been coming fast and furious in recent years – and abundantly accumulating.

Boehringer out tweets, pins, posts and shares its peers

The number of followers for pharma companies on Twitter has increased nearly 300% since 2013 – but has pharma got any better at communicating on social media?

Biosimilars, social media among 2015 expected FDA guidances

The FDA on 6 January issued its agenda, without specific dates, for new and revised draft guidances expected to be issued in 2015 by the Center for Drug Evaluation and Research (CDER), including the much anticipated documents affecting biosimilar products and drug makers' use of social media.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

SC065067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel